Availability and adaption of exercise programs in pediatric oncology during the COVID-19 pandemic and beyond: a nationwide follow-up survey of providers in Germany.

COVID-19 adaptions childhood cancer exercise program physical activity restrictions survey

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2024
Historique:
received: 17 01 2024
accepted: 11 03 2024
medline: 8 4 2024
pubmed: 8 4 2024
entrez: 8 4 2024
Statut: epublish

Résumé

The COVID-19 pandemic has presented major challenges to clinical practice and delivery of care programs throughout all health care systems. Exercise programs, that are implemented in most centers for pediatric oncology in Germany, are a relatively new care program however with high clinical impact and health benefits. The impact and consequences of the pandemic on the delivery and availability of exercise programs in Germany for pediatric cancer patients and survivors are unknown. A national survey analyzed restrictions, challenges and novel approaches of exercise program delivery and scientific research. A two-stage online survey was distributed to providers of exercise programs (acute clinics, non-clinical institutions, rehabilitation facilities) via the established Network ActiveOncoKids. Data was collected during the pandemic in 2022 and 2023 using a combination of open and closed questions. In total, The findings highlight the adaptability, the demand and the potential of exercise programs in pediatric oncology. We assume that exercise professionals have used the pandemic-related challenges to review and modify existing concepts and made adaptations according to local conditions and novel tools for the provision of exercise programs. Nevertheless, a conspicuous lack of exercise-related care has become evident in certain patients and survivors. Further expansion of programs is imperative to address and accommodate all pertinent needs.

Sections du résumé

Background UNASSIGNED
The COVID-19 pandemic has presented major challenges to clinical practice and delivery of care programs throughout all health care systems. Exercise programs, that are implemented in most centers for pediatric oncology in Germany, are a relatively new care program however with high clinical impact and health benefits.
Objective UNASSIGNED
The impact and consequences of the pandemic on the delivery and availability of exercise programs in Germany for pediatric cancer patients and survivors are unknown. A national survey analyzed restrictions, challenges and novel approaches of exercise program delivery and scientific research.
Method UNASSIGNED
A two-stage online survey was distributed to providers of exercise programs (acute clinics, non-clinical institutions, rehabilitation facilities) via the established Network ActiveOncoKids. Data was collected during the pandemic in 2022 and 2023 using a combination of open and closed questions.
Results UNASSIGNED
In total,
Discussion UNASSIGNED
The findings highlight the adaptability, the demand and the potential of exercise programs in pediatric oncology. We assume that exercise professionals have used the pandemic-related challenges to review and modify existing concepts and made adaptations according to local conditions and novel tools for the provision of exercise programs. Nevertheless, a conspicuous lack of exercise-related care has become evident in certain patients and survivors. Further expansion of programs is imperative to address and accommodate all pertinent needs.

Identifiants

pubmed: 38586153
doi: 10.3389/fped.2024.1372261
pmc: PMC10995395
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1372261

Informations de copyright

© 2024 Kesting, Gaser, Queisser, Götte, von Luettichau, Peters, Oberhoffer-Fritz and Gauß.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Sabine Kesting (S)

Department of Pediatrics and Children's Cancer Research Centre, Kinderklinik München Schwabing, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Department Health and Sport Sciences, Institute of Preventive Pediatrics, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Children's Oncology Network Bavaria, KioNet, Erlangen, Germany.

Dominik Gaser (D)

Department of Pediatrics and Children's Cancer Research Centre, Kinderklinik München Schwabing, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Department Health and Sport Sciences, Institute of Preventive Pediatrics, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Children's Oncology Network Bavaria, KioNet, Erlangen, Germany.

Jennifer Queisser (J)

Department of Pediatrics and Children's Cancer Research Centre, Kinderklinik München Schwabing, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Department Health and Sport Sciences, Institute of Preventive Pediatrics, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.

Miriam Götte (M)

Clinic of Pediatrics III, Hematology and Oncology, University Hospital Essen, Essen, Germany.
West German Cancer Center Essen, University Hospital Essen, Essen, Germany.

Irene von Luettichau (I)

Department of Pediatrics and Children's Cancer Research Centre, Kinderklinik München Schwabing, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Children's Oncology Network Bavaria, KioNet, Erlangen, Germany.

Christiane Peters (C)

Department Health and Sport Sciences, Institute of Preventive Pediatrics, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.

Renate Oberhoffer-Fritz (R)

Department Health and Sport Sciences, Institute of Preventive Pediatrics, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.

Gabriele Gauß (G)

Clinic of Pediatrics III, Hematology and Oncology, University Hospital Essen, Essen, Germany.

Classifications MeSH